Has Philip Schlager, MD received payments from drug or device companies?

Yes. Drug and device makers reported $435 in general payments to Philip Schlager, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Philip Schlager, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Philip Schlager, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Philip Schlager, MD

Otolaryngology · Carson City, NVNPI 1174587539

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $364 of the $435 with a category attached, or 83.7%. 6 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 43.1% of the total. 2025 is the largest year on record at $272, more than ten times the $26 reported in 2020. That places this record below the midpoint for otolaryngology clinicians in NV, where the typical reported total is $1,885.

$435in general payments, 2019–2025

Across 14 payments — averaging $31.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$188
GSK$137
Sanofi-aventis U.S. LLC$53
Stryker$26
AbbVie$16
Sanofi$15

What the payments were for

Food & beverage$36484%
Education$7116%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	7	$188
GSK	2	$137
Sanofi-aventis U.S. LLC	1	$53
Stryker	2	$26
AbbVie	1	$16
Sanofi	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$135
NUCALA$125

How this compares

$435 in reported general payments places this provider in the 20th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada →

Medicare billing

Part B allowed, 2024

$152,100

Medicare patients

836

Services billed

2,781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	196	$6,289
Pilocarpine Hcl	63	$4,329
Azelastine-FluticasoneAzelastine/Fluticasone	16	$2,630
Gabapentin	184	$2,302
Azelastine Hcl	84	$2,222
Amitriptyline Hcl	63	$870
Mupirocin	100	$779
Ofloxacin	25	$728
Clotrimazole	22	$630
Doxycycline Hyclate	24	$394
Montelukast Sodium	50	$393
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$257
Fluticasone Propionate	17	$248
ErythromycinErythromycin Base	14	$247
CefuroximeCefuroxime Axetil	17	$228

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Carson City

Paul ManoukianCarson City$7K
Ashley SikandHenderson$284K
Oluwafunmilola OkuyemiLas Vegas$60K
Jeannie KhavkinLas Vegas$22K
Lakeisha HenryHenderson$9K
Robert WangLas Vegas$9K
Suparna ShahLas Vegas$8K
Randall WeingartenHenderson$5K
Candice YipLas Vegas$5K
Daniel HiltonLas Vegas$5K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →